Actively Recruiting

Age: 18Years +
All Genders
NCT06056999

New Method to Differentiate Benign and Malignant Pulmonary Nodules.

Led by China-Japan Friendship Hospital · Updated on 2024-12-18

150

Participants Needed

1

Research Sites

91 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this observational clinical trial is to establish a new method for differentiating benign and malignant pulmonary nodules by peripheral blood detection in patients with pulmonary nodules (\<3cm). The main questions it aims to answer is: How to combine blood metabolomic mass spectrometry detection and artificial intelligence image analysis to establish a new model for differentiating benign and malignant pulmonary nodules. Participants will be asked provide 4 mL peripheral blood for the test.

CONDITIONS

Official Title

New Method to Differentiate Benign and Malignant Pulmonary Nodules.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years
  • Presence of pulmonary nodule smaller than 3 cm on CT imaging scheduled for biopsy or surgery
  • Up to two target lesions of the same density type allowed
  • Good health with ECOG performance status between 0 and 2
  • Adequate organ function as defined by blood counts and liver/kidney function tests
  • Ability to understand and voluntarily sign informed consent
Not Eligible

You will not qualify if you...

  • Imaging suggests possible metastasis to other sites
  • Two or more target lesions of different density types
  • History of malignant disease
  • Severe vascular lesions in last 3 months, active infections, severe cardiovascular, cerebrovascular, liver, renal, endocrine, or metabolic disorders
  • Contraindications to biopsy or surgery such as coagulation disorders or cardiorespiratory insufficiency
  • History of uncontrolled epilepsy, central nervous system disease, or psychiatric disorders affecting consent
  • Pregnant or breastfeeding women
  • Other conditions deemed unsuitable by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

China-Japan Friendship Hospital

Beijing, Beijing Municipality, China, 100029

Actively Recruiting

Loading map...

Research Team

G

Guangying Zhu, doctor

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here